| [Download PDF]
|Year : 2005 | Volume
| Issue : 4 | Page : 243--246
Pharmacological screening and evaluation of antiplasmodial activity of Croton zambesicus against Plasmodium berghei berghei infection in mice
JE Okokon1, KC Ofodum1, KK Ajibesin2, B Danladi2, KS Gamaniel3,
1 Department of Pharmacology & Toxicology, Faculty of Pharmacy, University of Uyo, Uyo, Nigeria
2 Department of Pharmacognosy & Traditional Medicine, Faculty of Pharmacy, University of Uyo, Uyo, Nigeria
3 Department of Pharmacology, National Institute for Pharmaceutical Research and Development, Abuja, Nigeria
J E Okokon
Department of Pharmacology & Toxicology, Faculty of Pharmacy, University of Uyo, Uyo
Objective: To evaluate the antiplasmodial activity of leaf extract of Croton zambesicus on chloroquine-sensitive Plasmodium berghei berghei infection in mice and to confirm its traditional use as a malarial remedy in Africa.
Materials and Methods : The ethanolic leaf extract of Croton zambesicus (50-200 mg/kg) was screened for blood schizontocidal activity against chloroquine-sensitive Plasmodium berghei berghei infection in mice. The schizontocidal activity during early and established infections as well as the repository activity were investigated.
Results: The extract demonstrated a dose-dependent chemosuppression or schizontocidal effect during early and in established infections, and also had repository activity. The activity was lower than that of the standard drugs (chloroquine 5 mg/kg, pyrimethamine 1.2 mg/kg/day).
Conclusion: The leaf extract possesses considerable antiplasmodial activity, which can be exploited in malaria therapy.
|How to cite this article:|
Okokon J E, Ofodum K C, Ajibesin K K, Danladi B, Gamaniel K S. Pharmacological screening and evaluation of antiplasmodial activity of Croton zambesicus against Plasmodium berghei berghei infection in mice.Indian J Pharmacol 2005;37:243-246
|How to cite this URL:|
Okokon J E, Ofodum K C, Ajibesin K K, Danladi B, Gamaniel K S. Pharmacological screening and evaluation of antiplasmodial activity of Croton zambesicus against Plasmodium berghei berghei infection in mice. Indian J Pharmacol [serial online] 2005 [cited 2021 Oct 27 ];37:243-246
Available from: https://www.ijp-online.com/text.asp?2005/37/4/243/16571
Croton zambesicus Muell Arg. (Euphorbiaceae) syn C. amabilis Muell. Arg.; syn. C. gratissimus Burch is an ornamental tree grown in villages and towns of Nigeria. It is a Guineo-Congolese species widely spread in tropical Africa. The leaf decoction is used in Benin as antihypertensive and antimicrobial (urinary infections). The Ibibios in Uruan area of Akwa Ibom State of Nigeria use the leaf traditionally as a remedy for malaria. Block et al reported that ent-trachyloban -3β-ol, a trachylobane diterpene, isolated from dichloro-methane extract of the leaves has cytotoxic activity on HeLa cells. The alkaloidal fractions of the leaf have been reported to possess weak activity against Kelebsiella pneumoniae, Pseudomonas aeruginosa, Bacillis megaterium , Bacillus subtilis, Escherichia coli , Proteus mirabilis, Staphylococcus aureus, Aspergillus niger, Microsporum species and Penicillium species. The alkaloidal fractions of the stem have also been reported to be active against all micro-organisms mentioned above. The essential oil found in the leaves contains P - cymene, linalool and beta-caryophyllene. The constituents of the essential oil also found in the flowering tops are pinene, limonene linalool, menthol, carvone, thymol, alpha - humulene and ceisnerolidol.
In spite of the large number of phytochemical and pharmacological studies carried out worldwide on Croton zambesicus, no scientific report has been quoted in the index medicus and NAPRALERT database on the antiplasmodial activity of this plant grown in Nigeria. We, therefore, evaluated the blood schizontocidal activity of the leaf extract of C. zambesicus against Plasmodium berghei infection in mice.
Materials and Methods
The leaves of Croton zambesicus Linn (Euphorbiaceae) were collected in March 2003, at Uyo area of Akwa Ibom State, Nigeria and authenticated by Dr. Uduak Eshiet, a taxonomist in the department of Botany, University of Uyo, Uyo, Nigeria. A specimen was deposited at the Faculty of Pharmacy herbarium, University of Uyo, Uyo (Voucher no. FPUU 209.)
Preparation of extract
Material: The fresh leaves (2 kg) of the plant were shade dried for 8 days and then powdered. 100 g of the powder was macerated in ethanol (300 ml) for 72 h. The liquid extract obtained was concentrated in vacuum at 40 oC. The yield was 3. 81%.
Phytochemical screening: A preliminary phytochemical screening of the powdered material was carried out employing the standard procedures to reveal the presence of saponin, flavonoids, tannins, alkaloids and glycosides.,
Swiss albino mice (25-32 g) of both sexes were obtained from the University of Uyo animal house, Uyo, Nigeria. The animals were housed in standard cages and acclimatized for a period of 10 days. The mice were maintained on standard pelleted diet and water ad libitum . Approval for the study was obtained from the Animal Ethics Committee, University of Uyo.
The chloroquine-sensitive Plasmodium berghei berghei strain was obtained from the National Institute of Pharmaceutical Research and Development, Abuja, Nigeria and was maintained in mice. The inoculum consisted of 5 x 107 P. berghei berghei parasitized red blood cells per ml. This was done by determining both the percentage parasitaemia and the red blood cell count of the donor mouse using the hemocytometer and diluting the blood with isotonic saline in proportions indicated by both determinations. Each mouse was inoculated on day 0, intraperitoneally, with 0.2 ml of infected blood containing about 1 x 107 P. berghei berghei parasitized red blood cells obtained from a donor mouse having about 64.0% parasitaemia.
The drugs and the extract used in this study were orally administered with the aid of a stainless metallic feeding cannula.
Evaluation of schizontocidal activity on early infection
A method described by Knight and Peters was used. The animals were divided into six groups of five mice each, and were administered 50,100,150 and 200 mg/kg/day doses of the extract, chloroquine 5 mg/kg/day and an equivalent volume of distilled water (control group) for four consecutive days (D0 to D3). On the fifth day (D4), thin blood films were made from the tail blood and fixed with methanol. The films were then stained with Giemsa stain and the percentage parasitemia was determined by counting the number of parasitized blood cells out of 500 red blood cells in random fields of the microscope. The average % suppression of parasitemia was calculated in comparison to controls as shown below.
Average % Average %
parasitemia in - parasitemia in
control groups treated group
Average % suppression = ----------------------------------------------x 100 Average % parasitemia in control
Evaluation of the repository activity
The repository activity was assessed by using the method described by Peters. The mice were divided into six groups of five animals each and administered 50, 100, 150 and 200 mg/kg/day doses of the extract, 1.2 mg/kg/day pyrimethamine (standard group) and distilled water (control) for four consecutive days (D0 to D3). On day five (D4), the mice were inoculated with P. berghei berghei. Seventy-two hours later, the parasitemia level was assessed by blood smears.
Evaluation of schizontocidal activity in established infection (Rane test)
A modified method similar to Ryley and Peters was used. On D0, standard inocula of 1 x 107 infected erythrocytes was injected in mice, intraperitoneally. Seventy-two hours later, the mice were divided into six groups (n = 5). Different doses of C. zambesicus extract (50, 100, 150 and 200 mg/kg/day) were orally administered to these groups. Chloroquine (5 mg/kg/day) was given to the standard group, and an equal volume of distilled water to the control group. The drug/extract was given once daily for 5 days. Thin films stained with Giemsa stain were prepared from tail blood for each mouse daily for 5 days to monitor the parasitemia level. The mean survival time for each group was determined arithmetically by finding the average of the survival time (days) of the mice (post inoculation) in each group over a period of 28 days (D0 to D28).
The data are expressed as mean±SEM. The data were statistically analysed using one-way ANOVA followed by Tukey-Kramer post test and values of P Phytochemical screening
Phytochemical screening of the ethanolic leaf extract of Croton zambesicus revealed the presence of compounds like saponins, alkaloids, terpenes, flavonoids and cardiac glycosides.
The ethanolic leaf extract of C. zambesicus produced a dose-dependent chemosuppressive effect at the different doses employed. (200, 150, 100 and 50 mg/kg doses with a chemosuppression of 80.7%, 75.0%, 70.7% and 38.4%, respectively - [Table 1]). The standard drug, chloroquine 5 mg/kg/day, caused 90 % suppression [Table 1], which was significantly (P Repository test
The ethanolic extract of C. zambesicus exerted a dose-dependent repository activity at the various doses employed (200, 150, 100 and 50 mg/kg/day doses causing 78.5%, 71.3%, 63.0% and 50.0% chemosuppression, respectively - [Table 2]). However, the standard agent pyrimethamine (1.2 mg/kg/day) caused a considerably higher (89.93%) chemosuppression than the extract-treated groups [Table 2] in which the highest dose produced 78.5% chemosuppression.
There was a dose-dependent reduction in parasitaemia with the extract, similar to the chloroquine-treated group, while the control group showed a daily increase in parasitemia. However, there was a daily reduction in the parasitemia level of the chloroquine-treated group [Figure 1]. Data in [Table 3] show that chloroquine (5 mg/kg/day) gave a mean survival time (m.s.t) of 27.1±0.7 days as compared to 11.5±3.5, 20.5±0.6, 21.3±0.8 and 25.5±0.5 days observed with 50, 100, 150 and 200 mg/kg/day doses of plant extract, respectively. It is noteworthy that some of the mice in the 200 mg/kg/day dose group survived the total duration of the study, as was the case with the chloroquine group. Although the values of m.s.t show that the plant extract significantly (P Croton zambesicus were carried out. Alkaloids, terpenes and flavonoids, which have been variously implicated in antiplasmodial activities of many plants, are also found in the extract studied. The antiplasmodial activity observed in this study could have resulted from a single or combined action of these compounds. However, the active principle responsible is yet to be identified.
The results indicate that the leaf extract possessed blood schizontocidal activity as evident from the chemosuppression obtained during the 4-day early infection test. The plant extract also exhibited repository activity, though the doses used could not produce suppression comparable to that of the standard drug (pyrimethamine 1.2 mg/kg/day). However, on established infection, the plant extract exhibited significant (P Croton zambesicus possesses antimalarial activity as seen in its ability to suppress Plasmodium berghei berghei infection in mice in all the three evaluation tests. These observations confirm the traditional use of the plant to treat malaria. Therefore, it would be interesting if the active principle could be isolated, identified and characterized from this promising medicinal plant.
The authors are grateful to Dr. H.O.C. Mbagwu and Mr. Nsikan Malachy of the Dept. of Pharmacology and Toxicology, University of Uyo, Uyo, for their assistance.
|1||Adjanohaun EJ, Adjakidje V, de Souza S. Contribution to Ethnobotanical and Floristic Studies in Benin Republic. Vol. 1 . Agency for Cultural and Technical Cooperation; 1989.|
|2||Block S, Stevigny C, De Pauw - Gillet MC, de Hoffman E, Llabres G, Adjakidje V, et al . ent-trachyloban-3β-ol, a New Cytotoxic Diterpene from C roton zambesicus. Planta Medica 2002;68:647-8.|
|3||Abo KA, Ogunleye Ashidi JS. Antimicrobial Potential of Spondias mombin, Croton zambesicus, and Zygotritonia crocea. Phytotherapy Research 1999;13:494-7.|
|4||Menut C, Lamaty G, Bessiere JM, Suleiman AM, Fendero P, Maidou E, et al . Aromatic Plants of Tropical central Africa. XXII. Volatile constituents of Croton aubrevillei, J Leonard and C. zambesicus Muell. Arg J Essen Oil Resear 1995;7:419-22.|
|5||Mekkawi AG. The essential oil of Croton zambesicus. Fitoterapia 1985;56:181-3.|
|6||Harbone JB. Phytochemical Methods. A guide to Modern Techniques of Plant Analysis. New York: Chapman and Hall; 1983|
|7||Evans WC. Trease and Evans Pharmacognosy. London: Bailliere tindall; 1987.|
|8||Odetola A, Bassir O. Evaluation of Antimalarial Properties of some Nigerian Medicinal Plants. In: Sofowora A, editor. Proceeding of African Bioscience Network, Fed. Min. of Science and Tech, Nigeria Soc. Of Pharmacolnosy and Drug Res. And Production Unit, University of Ife Organised Workshop, Ife; 1980.|
|9||Knight DJ, Peters W. The antimalarial action of N-benzyloxy dihydrotriazines.I. The actions of Clociguanil (BRL 50216) against rodent malaria and studies on its mode of action. Ann Trop Med Parasitol 1980;74:393-404.|
|10||Awe SO, Makinde JM. Antiplasmodial activity of Carica papaya against Plasmodium yoelli nigeriensis in mice. West Afr J Pharmacol Drug Res 1997;13:31-4.|
|11||Peters W. Drug resistance in Plasmodium berghei . Vincke and Lips, 1948: I chloroquine resistance. Expt Parasitol 1965;17:80-9.|
|12||Ryley JF, Peters W. The antimalarial activity of some quinolone esters. Am Trop Med Parasitol 1970;84:209-22.|
|13||Milliken W. Malaria and Antimalarial Plants in Roraima, Brazil. Trop Doct 1997;27:20-4.|
|14||Etkin NL. Antimalarial Plants used by Hansa in Northren Nigeria. Trop Doct 1997;27:12-6.|
|15||Kirby GC, O'Neill MJ, Philipson JD, Warhurst DC. In vitro studies on the mode of action of quassionoids with activity against chloroquine-resistant Plasmodium falciparum. Biochem Pharmacol 1989;38:4367-74.|